Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Exercise or conversion Director acquired 93,798 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy 10% owner bought 112,700 shares at an average $4.97 ($560,133)
  5. 4 Open-market buy 10% owner bought 136,300 shares at an average $5.02 ($683,704)
  6. 4 Open-market buy 10% owner bought 35,000 shares at $5.58 ($195,402)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy 10% owner bought 50,000 shares at an average $5.73 ($286,508)
  13. 4 Open-market buy 10% owner bought 25,900 shares at an average $4.85 ($125,666)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Exercise or conversion Director acquired 72,218 shares (option exercise)
  17. 3 Insider Initial Statement of Ownership
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 15 · 296 filings